Development and research in idiopathic thrombocytopenic purpura: An inflammatory and autoimmune disorder
Article first published online: 24 AUG 2006
Copyright © 2006 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Special Issue: 2nd Intercontinental Childhood ITP Study Group (ICIS) Expert Meeting on “Critical Issues and Future Research of ITP”, September 16–18, 2006, Yverdon, Switzerland
Volume 47, Issue S5, pages 685–686, 15 October 2006
How to Cite
Imbach, P. (2006), Development and research in idiopathic thrombocytopenic purpura: An inflammatory and autoimmune disorder. Pediatr. Blood Cancer, 47: 685–686. doi: 10.1002/pbc.20969
- Issue published online: 24 AUG 2006
- Article first published online: 24 AUG 2006
- Manuscript Received: 20 JUN 2006
- Manuscript Accepted: 20 JUN 2006
Bleeding and isolated thrombocytopenia in idiopathic thrombocytopenic purpura (ITP) are phenomena of a transient or long-term disturbed immune response. Since 1980, ITP has become a model for targeted therapeutic immunomodulation with still unclear mechanisms of action. The systematic analysis of ITP aims to determine more clearly defined patient subgroups for targeted therapy and to explore the complex immune disturbances in this autoimmune disorder. Pediatr Blood Cancer 2006;47:685–686. © 2006 Wiley-Liss, Inc.